BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,943,000 | +260.9% | 226,782 | +486.7% | 0.35% | +328.0% |
| Q4 2021 | $4,140,000 | -75.6% | 38,654 | -76.6% | 0.08% | -68.3% |
| Q3 2021 | $16,971,000 | -0.6% | 165,069 | -15.0% | 0.26% | +7.0% |
| Q2 2021 | $17,080,000 | +50.3% | 194,183 | +66.1% | 0.24% | +69.2% |
| Q1 2021 | $11,367,000 | -50.7% | 116,911 | -43.1% | 0.14% | -43.5% |
| Q4 2020 | $23,042,000 | +107.7% | 205,454 | +71.7% | 0.25% | +19.3% |
| Q3 2020 | $11,092,000 | +468.8% | 119,652 | +378.6% | 0.21% | +307.7% |
| Q2 2020 | $1,950,000 | -26.1% | 25,000 | -28.6% | 0.05% | +8.3% |
| Q4 2017 | $2,639,000 | – | 35,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |